OTC Healthcare in Portugal
Euromonitor International's OTC Healthcare in Portugal market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 129 | Publication date: Apr 2009
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Adult mouth care; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; OTC triptans; Vitamins and dietary supplements; Wound treatments
Executive summary
OTC healthcare achieves continued positive retail value growth in 2008
Despite the global economic slowdown, diminished consumer purchasing power and a slump in the morale of consumers OTC healthcare achieved continued positive retail value growth in 2008 as health and wellness remained a priority among the Portuguese. One of the factors from which OTC healthcare benefited was a ban on smoking in the workplace and in public spaces, which prompted many smokers to reduce their consumption of cigarettes. Analgesics also continued to drive retail value sales of OTC healthcare in 2008, as it remained the largest category in terms of retail value sales.
Ageing population and self-medication boost demand for OTC healthcare
Owing to the increasingly ageing Portuguese population, demand for OTC healthcare increased further in 2008. Ageing is a leading factor behind a wide range of diseases and as ageing consumers wish to live longer and age gracefully, demand for products in OTC healthcare has risen. There is strong demand for hair loss treatments, calming and sleeping products and also dietary supplements to prevent heart disease. On the other hand, consumers faced increasingly hectic lifestyles in 2008 and thus self-medication was a convenient alternative to having to spend time and money on visiting a doctor for minor ailments. Analgesics, in particular, has benefited from the trend of self-medication among consumers.
Trend of self-medication benefits popular brands
There are more than 100 companies operating in OTC healthcare in Portugal, some of which are domestic and the leaders of which are multinational players. Multinational players benefit from the preference among consumers for self-medication as this prompts them to opt for well-known brands, the results of which have been proven.
Increased distribution promotes growth of OTC healthcare
Following the liberalisation of the sale of medicinal products in OTC healthcare, the distribution landscape in OTC healthcare changed, as the focus was taken away from chemists/pharmacies. The number of distribution outlets for OTC healthcare increased and this helped to boost sales. In 2008, approximately 678 distribution outlets other than chemists/pharmacies outlets offered medicinal products in OTC healthcare. Nevertheless chemists/pharmacies remained the leading channel of distribution for OTC healthcare in 2008.
Constant value growth of OTC healthcare to remain positive
OTC healthcare is expected to continue to achieve positive constant value growth over the forecast period, driven by demand for NRT smoking cessation aids as more smokers in Portugal attempt to stop smoking and turn to products in OTC healthcare to help them. However, analgesics is expected to remain the largest category of OTC healthcare in terms of retail value sales over the forecast period, as the trend of self-medication is expected to increase further in Portugal and to continue to have a positive impact on OTC healthcare.
Table of contents
OTC HEALTHCARE IN PORTUGAL : MARKET INSIGHT
EXECUTIVE SUMMARY
OTC healthcare achieves continued positive retail value growth in 2008
Ageing population and self-medication boost demand for OTC healthcare
Trend of self-medication benefits popular brands
Increased distribution promotes growth of OTC healthcare
Constant value growth of OTC healthcare to remain positive
KEY TRENDS AND DEVELOPMENTS
Economic crisis hampers growth of some categories of OTC healthcare
Ageing population, a key driver of demand for products in OTC healthcare
Self-medication, an accelerator of growth of OTC healthcare
Smoking ban boosts demand for products in NRT smoking cessation aids
Competition between distribution channels positively impacts OTC healthcare
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 2 Life Expectancy at Birth 2003-2008
MARKET DATA
MARKET INDICATORS
Table 3 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 4 Life Expectancy at Birth 2003-2008
MARKET DATA
Table 5 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 6 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 7 OTC Healthcare Company Shares by Value 2004-2008
Table 8 OTC Healthcare Brand Shares by Value 2005-2008
Table 9 Penetration of Private Label by Sector 2003-2008
Table 10 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 11 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 12 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 13 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
Table 14 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 15 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 16 OTC Healthcare Company Shares by Value 2004-2008
Table 17 OTC Healthcare Brand Shares by Value 2005-2008
Table 18 Penetration of Private Label by Sector 2003-2008
Table 19 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 20 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 21 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 22 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
APPENDIX
OTC Registration and Classification
EU Legislation
Self-medication and Preventative Medicine
Generics
Switches
DEFINITIONS
Summary 1 Research Sources
LOCAL COMPANY PROFILES - PORTUGAL
DERMOTECA-PRODUTOS QUIMICOS E DERMATOLOGICOS SA - OTC HEALTHCARE - PORTUGAL
STRATEGIC DIRECTION
KEY FACTS
Summary 2 Dermoteca-Produtos Quimicos e Dermatologicos SA: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 3 Dermoteca-Produtos Quimicos e Dermatologicos SA: Competitive Position 2008
GRUNENTHAL SA - OTC HEALTHCARE - PORTUGAL
STRATEGIC DIRECTION
KEY FACTS
Summary 4 Grunenthal SA: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 5 Laboratórios Andrómaco SA: Competitive Position 2008
LABORATORIO J NEVES, LDA - OTC HEALTHCARE - PORTUGAL
STRATEGIC DIRECTION
KEY FACTS
Summary 6 Laboratorio J Neves Lda: Key Facts
Summary 7 Laboratorio J Neves Lda: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 8 Laboratorio J Neves Lda: Competitive Position 2008
LABORATóRIO MEDINFAR PRODUTOS FARMACêUTICOS SA - OTC HEALTHCARE - PORTUGAL
STRATEGIC DIRECTION
KEY FACTS
Summary 9 Laboratório Medinfar Produtos Farmacêuticos SA: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 10 Laboratório Medinfar Produtos Farmacêuticos SA: Competitive Position 2008
NEO-FARMACêUTICA, LDA - OTC HEALTHCARE - PORTUGAL
STRATEGIC DIRECTION
KEY FACTS
Summary 11 Neo-Farmacêutica Lda: Key Facts
Summary 12 Neo-Farmaceutica Lda: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 13 Neo-Farmacêutica Lda: Competitive Position 2008
PEISFAR SA - OTC HEALTHCARE - PORTUGAL
STRATEGIC DIRECTION
KEY FACTS
Summary 14 Peisfar SA: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 15 Peisfar SA: Competitive Position 2008
ANALGESICS IN PORTUGAL
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 23 Sales of Analgesics by Subsector: Value 2003-2008
Table 24 Sales of Analgesics by Subsector: % Value Growth 2003-2008
Table 25 Herbal vs Standard Topical Analgesics 2003-2008
Table 26 Topical Analgesics by Format: % Value Breakdown 2004-2008
Table 27 Analgesics Company Shares by Value 2004-2008
Table 28 Analgesics Brand Shares by Value 2005-2008
Table 29 Forecast Sales of Analgesics by Subsector: Value 2008-2013
Table 30 Forecast Sales of Analgesics by Subsector: % Value Growth 2008-2013
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN PORTUGAL
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 31 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2003-2008
Table 32 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2003-2008
Table 33 Sales of Decongestants by Type: Value 2003-2008
Table 34 Sales of Decongestants by Type: % Value Growth 2003-2008
Table 35 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2003-2008
Table 36 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2004-2008
Table 37 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2005-2008
Table 38 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2008-2013
Table 39 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2008-2013
DIGESTIVE REMEDIES IN PORTUGAL
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 40 Sales of Digestive Remedies by Subsector: Value 2003-2008
Table 41 Sales of Digestive Remedies by Subsector: % Value Growth 2003-2008
Table 42 Herbal vs Standard Digestive Remedies 2003-2008
Table 43 Digestive Remedies Company Shares by Value 2004-2008
Table 44 Digestive Remedies Brand Shares by Value 2005-2008
Table 45 Forecast Sales of Digestive Remedies by Subsector: Value 2008-2013
Table 46 Forecast Sales of Digestive Remedies by Subsector: % Value Growth 2008-2013
MEDICATED SKIN CARE IN PORTUGAL
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 47 Sales of Medicated Skin Care by Subsector: Value 2003-2008
Table 48 Sales of Medicated Skin Care by Subsector: % Value Growth 2003-2008
Table 49 Herbal vs Standard Medicated Skin Care 2003-2008
Table 50 Acne Treatments by Format: % Value Breakdown 2004-2008
Table 51 Medicated Skin Care Company Shares by Value 2004-2008
Table 52 Medicated Skin Care Brand Shares by Value 2005-2008
Table 53 Acne Treatments Brand Shares by Value 2005-2008
Table 54 Hair Loss Treatments Brand Shares by Value 2005-2008
Table 55 Forecast Sales of Medicated Skin Care by Subsector: Value 2008-2013
Table 56 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2008-2013
VITAMINS AND DIETARY SUPPLEMENTS IN PORTUGAL
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 57 Dietary Supplements: Brand Ranking by Positioning 2008
SECTOR DATA
Table 58 Sales of Vitamins and Dietary Supplements by Subsector: Value 2003-2008
Table 59 Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2003-2008
Table 60 Folic Acid v Other B Vitamins 2004-2008
Table 61 Dietary Supplements by Positioning 2006-2008
Table 62 Vitamins and Dietary Supplements Company Shares by Value 2004-2008
Table 63 Vitamins and Dietary Supplements Brand Shares by Value 2005-2008
Table 64 Vitamins Brand Shares by Value 2005-2008
Table 65 Dietary Supplements Brand Shares by Value 2005-2008
Table 66 Forecast Sales of Vitamins and Dietary Supplements by Subsector: Value 2008-2013
Table 67 Forecast Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2008-2013
NRT SMOKING CESSATION AIDS IN PORTUGAL
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR INDICATORS
Table 68 Number of Smokers by Gender 2003-2008
SECTOR DATA
Table 69 Sales of Smoking Cessation Aids by Subsector: Value 2003-2008
Table 70 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2003-2008
Table 71 NRT Gum Flavours: % Value Breakdown 2006-2008
Table 72 Smoking Cessation Aids Company Shares by Value 2004-2008
Table 73 Smoking Cessation Aids Brand Shares by Value 2005-2008
Table 74 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2008-2013
Table 75 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2008-2013
EYE CARE IN PORTUGAL
HEADLINES
SECTOR DATA
Table 76 Sales of Eye Care by Subsector: Value 2003-2008
Table 77 Sales of Eye Care by Subsector: % Value Growth 2003-2008
Table 78 Standard Eye Care by Type: % Value Breakdown 2007-2008
Table 79 Eye Care Company Shares by Value 2004-2008
Table 80 Eye Care Brand Shares by Value 2005-2008
Table 81 Forecast Sales of Eye Care by Subsector: Value 2008-2013
Table 82 Forecast Sales of Eye Care by Subsector: % Value Growth 2008-2013
EAR CARE IN PORTUGAL
HEADLINES
SECTOR DATA
Table 83 Sales of Ear Care: Value 2003-2008
Table 84 Sales of Ear Care: % Value Growth 2003-2008
Table 85 Ear Care Company Shares by Value 2004-2008
Table 86 Ear Care Brand Shares by Value 2005-2008
Table 87 Forecast Sales of Ear Care: Value 2008-2013
Table 88 Forecast Sales of Ear Care: % Value Growth 2008-2013
ADULT MOUTH CARE IN PORTUGAL
HEADLINES
SECTOR DATA
Table 89 Sales of Adult Mouth Care: Value 2003-2008
Table 90 Sales of Adult Mouth Care: % Value Growth 2003-2008
Table 91 Adult Mouth Care Company Shares by Value 2004-2008
Table 92 Adult Mouth Care Brand Shares by Value 2005-2008
Table 93 Forecast Sales of Adult Mouth Care: Value 2008-2013
Table 94 Forecast Sales of Adult Mouth Care: % Value Growth 2008-2013
CALMING AND SLEEPING PRODUCTS IN PORTUGAL
HEADLINES
SECTOR DATA
Table 95 Sales of Calming and Sleeping Products: Value 2003-2008
Table 96 Sales of Calming and Sleeping Products: % Value Growth 2003-2008
Table 97 Calming and Sleeping Products Company Shares by Value 2004-2008
Table 98 Calming and Sleeping Products Brand Shares by Value 2005-2008
Table 99 Forecast Sales of Calming and Sleeping Products: Value 2008-2013
Table 100 Forecast Sales of Calming and Sleeping Products: % Value Growth 2008-2013
WOUND TREATMENTS IN PORTUGAL
HEADLINES
SECTOR DATA
Table 101 Sales of Wound Treatments by Subsector: Value 2003-2008
Table 102 Sales of Wound Treatments by Subsector: % Value Growth 2003-2008
Table 103 Wound Treatments Company Shares by Value 2004-2008
Table 104 Wound Treatments Brand Shares by Value 2005-2008
Table 105 Forecast Sales of Wound Treatments by Subsector: Value 2008-2013
Table 106 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2008-2013
OTC OBESITY IN PORTUGAL
HEADLINES
SECTOR DATA
Table 107 Forecast Sales of OTC Obesity: Value 2009-2013
Table 108 Forecast Sales of OTC Obesity: % Value Growth 2009-2013
EMERGENCY CONTRACEPTION IN PORTUGAL
HEADLINES
SECTOR DATA
Table 109 Sales of Emergency Contraception: Value 2003-2008
Table 110 Sales of Emergency Contraception: % Value Growth 2003-2008
Table 111 Emergency Contraception Company Shares by Value 2004-2008
Table 112 Emergency Contraception Brand Shares by Value 2005-2008
Table 113 Forecast Sales of Emergency Contraception: Value 2008-2013
Table 114 Forecast Sales of Emergency Contraception: % Value Growth 2008-2013
OTC TRIPTANS IN PORTUGAL
HEADLINES